Ocular Ischaemic Syndrome - PowerPoint PPT Presentation

About This Presentation
Title:

Ocular Ischaemic Syndrome

Description:

Ocular Ischaemic Syndrome Dr Gulrez Ansari Department of Ophthalmology Watford General Hospital 3rd November 2004 Ocular Ischaemic Syndrome A severe form of chronic ... – PowerPoint PPT presentation

Number of Views:679
Avg rating:3.0/5.0
Slides: 20
Provided by: eyelasers
Category:

less

Transcript and Presenter's Notes

Title: Ocular Ischaemic Syndrome


1
Ocular Ischaemic Syndrome
  • Dr Gulrez Ansari
  • Department of Ophthalmology
  • Watford General Hospital
  • 3rd November 2004

2
Ocular Ischaemic Syndrome
  • A severe form of chronic ischaemia of both
    anterior and posterior segments of the eye as
    well as other orbital structures supplied by the
    ophthalmic artery.
  • Chronic hypoperfusion when carotid artery
    stenosis gt 90
  • Usually unilateral
  • Age 50-80 yrs
  • MaleFemale21

3
Symptoms
  • Vision loss Sudden (41)
  • Gradual (28)
  • Transient (15)
  • ?Precipitated by exposure to bright lights
    (bright light amaurosis)
  • Pain Ocular / Orbital
  • Incidental asymptomatic finding

4
Signs
  • Anterior Segment
  • Dilated Episcleral vessels
  • Corneal edema
  • AC Cells
  • Flare (ischemic pseudoinflammatory uveitis)
  • Mid-dilated poorly reactive pupil
  • Cataract
  • Iris atrophy
  • Iris neovascularisation angle
    neovascularisation
  • Neovasuclar Glaucoma

5
Gonioscopy Angle neovascularisation
6
Signs
  • Posterior Segment
  • Disc NVD, Easily inducible retinal artery
    pulsation, AION (rare)
  • Vessels Venous dilatation (no tortuosity)
  • Periphery Mid peripheral haemorrhages,
    Microaneurysms
  • Macular oedema
  • Ischaemic changes Retinal arteriolar narrowing,
    retinal capillary non-perfusion

7
Retinal Haemorrhages
8
Differential Diagnosis
  • Other causes of iris neovascularisation
  • Proliferative diabetic retinopathy
  • Ischaemic CRVO

9
Systemic evaluation
  • Systemic associations
  • Diabetes mellitus (56)
  • Hypertension (50-73)
  • Ischaemic heart disease (38-48)
  • Cerebrovascular disease (27-31)
  • Giant cell arteritis (rare)

10
Investigations
  • FFA
  • ?Aid in confirmation of diagnosis,
  • ?Demonstrate retinal capillary non-perfusion to
    validate PRP
  • Delayed patchy choroidal filling
  • ?ed retinal arteriovenous circulation times
  • Areas of retinal capillary non-perfusion
  • Late leakage from arterioles and veins
  • Macular oedema

11
FFA
12
Visual Fields
  • Normal (23)
  • Central scotomas (27)
  • Nasal defects (23)
  • Centrocaecal defects (5)
  • Central or temporal islands (22)

13
Carotid artery ultrasound
  • Carotid occlusion, usually 90 or more
  • Colour Doppler Imaging (CDI) of retrobulbar
    circulation
  • Reduced peak systolic velocities in ophthalmic
    central retinal arteries
  • Conitnuous / intermittent reversal of ophthalmic
    artery blood flow
  • Limitation Difficult to reliably reproduce
    orbital blood flow measurements
  • ERG
  • Diminished b- and a- waves

14
Management
  • Ophthalmologist
  • Physician/Neurologist
  • Vascular surgeon

15
Ocular treatment
  • Anterior segment inflammation
  • Topical steroids and cycloplegics
  • Ablation of retinal ischaemia
  • Early FFA, Only if retinal ischaemia gtgt
    3000-5000 burns of 200-500µm spot size
  • Control of IOP Neovascular glaucoma
  • ?Medical therapy (topical ß blockers,
    cycloplegics, oral carbonic anhydrase inhibitors)
  • ?Surgery (trab with mitomycin C, Tube shunt
    procedure)
  • ?Ciliary body ablation (cyclocryotherapy,
    laser cyclophotocoagulation NdYAG / Diode
    laser)

16
Medical Treatment
  • Full medical and neurological assessment
  • Aspirin
  • Treatment of hypertension, diabetes
  • Stop smoking

17
Carotid Surgery
  • Of benefit in symptomatic Cerebral ischaemia when
    there is gt70 carotid artery stenosis
  • Pts with severe carotid stenosis and a recent
    cerebral rather than ocular event had a greater
    risk of stroke when taking medical treatment
    therefore a greater benefit from surgery
  • Impact on visual prognosis unclear (no randomized
    controlled studies)
  • In one series 7 improved Vn, 33 no change,
    60 worsened

18
Conclusion
  • Rare, but severe condition
  • Leads to significant visual loss and chronic
    ocular pain
  • Iris neovascularisation is an indicator of poor
    visual prognosis
  • 5 year mortality rate 40
  • Majority of deaths are due to cardiac disease

19
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com